What is the official website of Eurofins Biomnis ?

The official website of Eurofins Biomnis is https://www.eurofins-biomnis.com.

What is Eurofins Biomnis's cybersecurity risk score?

Eurofins Biomnis has an AI-generated cybersecurity risk score of 759 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins Biomnis experienced?

According to Rankiteo, Eurofins Biomnis currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins Biomnis been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins Biomnis has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins Biomnis have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins Biomnis is not certified under SOC 2 Type 1.

Does Eurofins Biomnis have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins Biomnis does not hold a SOC 2 Type 2 certification.

Does Eurofins Biomnis comply with GDPR ?

According to Rankiteo, Eurofins Biomnis is not listed as GDPR compliant.

Does Eurofins Biomnis have PCI DSS certification ?

According to Rankiteo, Eurofins Biomnis does not currently maintain PCI DSS compliance.

Does Eurofins Biomnis comply with HIPAA ?

According to Rankiteo, Eurofins Biomnis is not compliant with HIPAA regulations.

Does Eurofins Biomnis have ISO 27001 certification ?

According to Rankiteo,Eurofins Biomnis is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins Biomnis operate in ?

Eurofins Biomnis operates primarily in the Medical and Diagnostic Laboratories industry.

How many employees does Eurofins Biomnis have ?

Eurofins Biomnis employs approximately 739 people worldwide.

Does Eurofins Biomnis own any subsidiaries ?

Eurofins Biomnis presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins Biomnis have ?

Eurofins Biomnis's official LinkedIn profile has approximately 16,301 followers.

Does Eurofins Biomnis have a Crunchbase profile ?

No, Eurofins Biomnis does not have a profile on Crunchbase.

Does Eurofins Biomnis have a LinkedIn profile ?

Yes, Eurofins Biomnis maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/laboratoire-biomnis.

How many cybersecurity incidents has Eurofins Biomnis experienced ?

As of August 10, 2026, Rankiteo reports that Eurofins Biomnis has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins Biomnis have ?

Eurofins Biomnis has an estimated 180 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Eurofins Biomnis

Boost Score +25 with badge (5 left)

759

/1000

Fair

784

/1000

Fair

Eurofins Biomnis Vendor Cyber Rating & Cyber Score

eurofins-biomnis.com

Add Your Compliance Badge

European leader in the sector of specialized medical pathology, Eurofins Biomnis carries out over 32,000 analyses per day from a range of over 2,500 available tests, including specialized tests for which the company has the appropriate authorizations. Founded in 1897 by Marcel Mérieux, Eurofins Biomnis remains the leader in the field of specialized medical pathology in France. It has kept its position through continuous technological innovation and investment, particularly in areas such as female biology, oncology and personalized medicine, as well as chromosomal and molecular genetics. The laboratory also stands out through its expertise in clinical research and biobanking, thanks to its dedicated infrastructure. With 120 years of

Eurofins Biomnis A.I CyberSecurity Scoring

Scoring History

Eurofins Biomnis

Eurofins Biomnis CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Eurofins Biomnis Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Eurofins Biomnis

Incidents vs Medical and Diagnostic Laboratories Industry Avg (This Year)

No incidents recorded for Eurofins Biomnis in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins Biomnis in 2026.

Incident Types Eurofins Biomnis vs Medical and Diagnostic Laboratories Industry Avg (This Year)

No incidents recorded for Eurofins Biomnis in 2026.

Incident History - Eurofins Biomnis (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins Biomnis Subsidiaries

Eurofins Biomnis

Medical and Diagnostic Laboratories

Website: https://www.eurofins-biomnis.com

Company Size: 739

EurofinsBiotechnology Research

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins PSS Insourcing SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins AdvinusResearch Services

Eurofins Advinus Agrosciences IndiaResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins BioPharma Product Testing India Pharmaceutical Manufacturing

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Product ChemistryResearch Services

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins Environment Testing (USA)Environmental Services

Eurofins GenomicsBiotechnology Research

Eurofins Food AssuranceProfessional Services

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreBiotechnology Research

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Central LaboratoryBiotechnology Research

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins Clinical DiagnosticsBiotechnology

Eurofins ChileFood and Beverage Services

Eurofins ViracorMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins DiscoverXBiotechnology Research

Eurofins Agro & HortiResearch Services

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Loading…

Eurofins Biomnis Similar Companies

Quest Diagnostics

questdiagnostics.com

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

Dasa

cb dasa.com.br

A Dasa é uma das maiores empresas de saúde do mundo, líder em medicina diagnóstica no Brasil. Trabalha para transformar sua especialização, alcance e escala em acesso à saúde de qualidade e cuidado humanizado. A empresa faz parte da vida de mais de 20 milhões de pessoas por ano, com alta tecnologia, amplo portfólio de exames e serviços e foco na melhor experiência em saúde. Com mais de 25 mil colaboradores e mais de 350 mil médicos parceiros, processa mais de 414 milhões de exames por ano em suas mais de 40 marcas presentes em todo o território nacional. Essa capilaridade única torna a Dasa a companhia de saúde que mais se relaciona com as pessoas, oferecendo soluções conectadas à realidade e à diversidade do país. Com uma governança baseada em gestão disciplinada e capacidade de execução, a empresa avança como uma organização inovadora, focada e sustentável, sempre pautada pela excelência médica e pelo compromisso com a sustentabilidade do setor da saúde.

Loading…

NEWS

Eurofins Biomnis CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-19374

SUMMARY

A security vulnerability has been detected in adafap api-mcp up to 92b9a5d04acfec165c7d4ef852496593aa87be06. This affects the function customAxios of the file app/api/proxy/route.ts of the component Proxy API Endpoint. The manipulation of the argument url leads to server-side request forgery. The attack is possible to be carried out remotely. This product adopts a rolling release strategy to maintain continuous delivery. Therefore, version details for affected or updated releases cannot be specified. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-09

Updated

Date2026-08-09

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-19373

SUMMARY

A weakness has been identified in PhialsBasement KoboldCPP-MCP-Server 1.0.0. Affected by this issue is the function makeRequest of the file src/index.ts of the component BaseConfigSchema. Executing a manipulation of the argument apiUrl can lead to server-side request forgery. It is possible to launch the attack on the local host. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-09

Updated

Date2026-08-09

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-19372

SUMMARY

A security flaw has been discovered in Handwriting-OCR handwriting-ocr-mcp-server 0.1.0. Affected by this vulnerability is the function fs.readFileSync of the file src/index.ts of the component upload_document. Performing a manipulation of the argument File results in path traversal. Attacking locally is a requirement. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-09

Updated

Date2026-08-09

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-19371

SUMMARY

A vulnerability was identified in Nikolaibibo claude-comfyui-mcp 1.0.0. Affected is the function copyFileSync of the file src/tools/utils.ts of the component comfy_upload_image. Such manipulation of the argument image_path leads to path traversal. An attack has to be approached locally. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-09

Updated

Date2026-08-09

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-12372

SUMMARY

A Server-Side Request Forgery (SSRF) vulnerability exists in nltk/nltk versions 3.9.4 and the current develop branch. The `nltk.pathsec.validate_network_url()` function, intended to prevent SSRF by rejecting internal network addresses, fails to reject IPs in the RFC 6598 shared address space (`100.64.0.0/10`). This occurs because Python's `ipaddress` module does not classify such addresses as `is_private` or `is_global`, and the current guard only checks `is_private` and a few explicit categories. An attacker who can influence a URL passed to NLTK's network-loading helpers can exploit this vulnerability to make a strict-mode application send requests to shared-address-space hosts, potentially exposing non-public infrastructure reachable from the application host. The impact is limited to SSRF-style confidentiality exposure, with no code execution claimed.

Published

Date2026-08-09

Updated

Date2026-08-09

RISK INFORMATION (Score: 3.7)

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.2

REFERENCES

https://huntr.com/bounties/2911b643-571c-42e4-b0c2-9a1fa6f491db

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…